4.7 Article

Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate

期刊

BLOOD
卷 113, 期 8, 页码 1856-1859

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-03-145789

关键词

-

资金

  1. CIRM fellowship (San Francisco, CA)
  2. NIH
  3. Margaret Early Foundation Award (Los Angeles, CA)
  4. American Heart Society (Burlin-game, CA)
  5. Concern Foundation (Beverly Hills, CA)
  6. American Cancer Society (Atlanta, GA)
  7. March of Dimes Foundation (White Plains, NY)
  8. NIH/NHLBI (National Heart, Lung, and Blood Institute) [1R21HL082643-01]

向作者/读者索取更多资源

Specification of endothelial cell (EC) fate during vascular development is controlled by distinct key regulators. While Notch plays an essential role in induction of arterial phenotypes, COUP-TFII is required to maintain the venous EC identity. Homeodomain transcription factor Prox1 functions to reprogram venous ECs to lymphatic endothelial cells (LECs). Here, we report that the venous EC fate regulator COUP-TFII is expressed in LECs throughout development and physically interacts with Prox1 to form a stable complex in various cell types including LECs. We found that COUP-TFII functions as a coregulator of Prox1 to control several lineage-specific genes including VEGFR-3, FGFR-3, and neuropilin-1 and is required along with Prox1 to maintain LEC phenotype. Together, we propose that the physical and functional interactions of the 2 proteins constitute an essential part in the program specifying LEC fate and may provide the molecular basis for the hypothesis of venous EC identity being the prerequisite for LEC specification. (Blood. 2009;113:1856-1859)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据